Herve Brailly

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Herve Brailly

Herve Brailly is recorded as CEO at Innate Pharma SA (IPHA). Herve Brailly has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Innate Pharma SA on September 25, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Herve Brailly's recent earnings-call comments and cite the source calls.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Innate Pharma SA (IPHA)
CEO

Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

Innate Pharma SA

IPHA

Current role

CEO

3 appearances Latest appearance 2025-09-25

View calls and events

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Annual General Meeting Individual shareholders meeting Innate Pharma SA (IPHA)
2025-09-25
Earnings call Innate Pharma SA Q2 FY2024 Earnings Call Innate Pharma SA (IPHA)
2024-06-25
Earnings call Innate Pharma SA Q4 FY2023 Earnings Call Innate Pharma SA (IPHA)
2023-12-31